<DOC>
	<DOCNO>NCT00300404</DOCNO>
	<brief_summary>We investigate whether add-on specific antitoxoplasmatic medication positive effect individual schizophrenia major depression seropositive Toxoplasma gondii ( TG ) infection . As TG modulate neurotransmitter metabolism affect serotonin dopamine hypothesize chronic persistent infection might play role depressive psychotic symptomatology . Therefore , basis ex juvantibus approach , specific anti TG medication might improve psychiatric symptomatology affect patient . This investigated double-blind , placebo-controlled , randomized treatment trial .</brief_summary>
	<brief_title>Effect Specific Anti-Toxoplasmatic Add-on Medication Toxoplasma Gondii Seropositive Individuals With Schizophrenia Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Schizophrenia Major Depression Both gender Adult Patients able give inform consent Additional diagnosis substance abuse/dependency Continuous treatment medication compatible study medication Medical status compatible study medication Any condition increase study risk considerably Pregnancy , nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Psychosis</keyword>
	<keyword>Depression</keyword>
	<keyword>Affective Disorder</keyword>
</DOC>